Corcept Therapeutics
CORT
#2466
Rank
C$9.98 B
Marketcap
C$91.24
Share price
-1.97%
Change (1 day)
-14.62%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: C$9.98 Billion

As of November 2026 Corcept Therapeutics has a market cap of C$9.98 Billion. This makes Corcept Therapeutics the world's 2466th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026C$9.98 B-16.27%
2025C$11.92 B51.18%
2024C$7.88 B77.65%
2023C$4.44 B49.68%
2022C$2.96 B1.84%
2021C$2.91 B-24.82%
2020C$3.87 B114.06%
2019C$1.81 B-13.53%
2018C$2.09 B-19.21%
2017C$2.59 B139.21%
2016C$1.08 B43.02%
2015C$0.75 B114.57%
2014C$0.35 B3.46%
2013C$0.34 B140.38%
2012C$0.14 B-51.56%
2011C$0.29 B4.89%
2010C$0.27 B52.87%
2009C$0.18 B196.1%
2008C$61.71 M-49.37%
2007C$0.12 B230.82%
2006C$36.85 M-61.7%
2005C$96.21 M-43.39%
2004C$0.16 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Corcept Therapeutics was reported to be:

C$10.18 Billion
by Nasdaq info icon info icon
C$10.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$934.41 B 9,257.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$411.20 B 4,017.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$225.54 B 2,158.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.730 T 17,225.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$476.70 B 4,673.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$173.97 B 1,642.22%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$1.80 B-81.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.17 B-88.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$16.92 B 69.52%๐Ÿ‡บ๐Ÿ‡ธ USA